We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

QuidelOrtho

Develops, manufactures and markets rapid diagnostic tests that focus on infectious diseases, reproductive health, and... read more Featured Products: More products

Download Mobile App





QuidelOrtho Demonstrates Advanced Diagnostic Laboratory Solutions across Healthcare Continuum

By LabMedica International staff writers
Posted on 29 Jul 2024

At the Association for Diagnostics & Laboratory Medicine (ADLM) 2024 conference, QuidelOrtho Corporation (San Diego, CA, USA) is presenting its flexible and reliable solutions that deliver quality diagnostic results across the entire healthcare continuum - from home to hospital, lab to clinic. More...

QuidelOrtho is providing onsite demonstrations of its diverse product lines including Vitros automation solutions which can reduce manual steps, increase efficiency, and free up lab staff to focus on the delivery of quality results while reducing operational costs. QuidelOrtho is also demonstrating the Vitros XT 7600 system which offers a full clinical chemistry and immunoassay menu in one easy-to-use system that delivers industry-leading uptime. The system’s built-in technologies improve efficiency and quality, allowing for scalable automation solutions that streamline workflow. Visitors to QuidelOrtho’s booth at ADLM 2024 can experience the Vitros XT 3400 Chemistry System which is powered by intelligent technologies and digital imaging technology to help labs meet routine testing needs, with proven high-quality results and system reliability in a small footprint. QuidelOrtho is also demonstrating the Ortho Vision Max Swift analyzer which is built on the proven design of the Ortho Vision platform and maximizes efficiency with dependable full menu automation.

Additionally, attendees can also join an insightful session sponsored by QuidelOrtho on "How labs evolve when Sigma metrics are provided automatically." In addition to exploring how having assay Sigma metrics at the fingertips can transform lab management, attendees can learn what industry experts did with their data, the improvements they made, and how it impacted their operations. QuidelOrtho is also sponsoring the Society of Young Clinical Laboratorians (SYCL) events at ADLM 2024, demonstrating its commitment to supporting the next generation of clinical laboratorians and their professional development.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Automated Clinical Chemistry Analyzer
Envoy 500+
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.